KTLA

RNA Therapeutics Receives Feedback from FDA for the First-in-class mRNA-based Delivery of Therapeutic Protein Promising Affordable Biological Drugs

CHICAGO, Aug. 19, 2024 /PRNewswire/ -- RNA Therapeutics, a clinical-stage biotechnology company focused on innovative applications of mRNA-based delivery systems for therapeutic proteins and vaccines, ...

Avidity Biosciences (RNA) Announces Positive One-Year Data For its, Del-Zota

Avidity Biosciences, Inc. (NASDAQ:RNA) is one of the Best Performing Long Term Stocks According to Analysts. On September 10, ...
Business Wire

Launch of Aptadir Therapeutics With a Novel Class of RNA Inhibitors

MILAN--(BUSINESS WIRE)--Aptadir Therapeutics (Aptadir), a biotech company developing RNA inhibitor-based therapeutics for treating intractable cancers and genetic conditions, announces its launch and ...
Mena FN

UTR Therapeutics Publishes Landmark Preclinical Data In Frontiers In Pharmacology Supporting IND Submission For First-In-Class C-MYC RNA Therapeutic

Pancreatic cancer is among the most aggressive and treatment-resistant malignancies, with a five-year survival rate below 12%. Central to its pathology is the overexpression of c-MYC , a transcription ...

UBRIGENE BIOSCIENCES INC: uBriGene Unveils V2.0 RNA-LNP iPSC Reprogramming Kit Optimized for PBMCs and Hard-to-Reprogram Cells

GERMANTOWN, MD / ACCESS Newswire / September 17, 2025 / uBriGene Biosciences, a leader in CGT CDMO and iPSC manufacturing ...
Purdue University

Kasinski awarded V Foundation Translational Grant to advance first-in-class targeted RNA therapies

Andrea Kasinski, Purdue Institute for Cancer Research (PICR) deputy director and professor of biological sciences in Purdue’s College of Science, has been awarded a competitive translational grant ...
KTLA

Circular Genomics Receives $250K Investment from the Alzheimer's Drug Discovery Foundation (ADDF) to Advance First-in-Class Circular RNA Blood-Based Biomarker Tests for the ...

SAN DIEGO, July 8, 2025 /PRNewswire/ -- Circular Genomics, Inc., a global leader in circular RNA (circRNA) biomarkers for precision neurology and psychiatry, today announced it has received a $250,000 ...